Structural understanding of SARS-CoV-2 virus entry to host cells

Area of Science:

• Structural virology
• Molecular biology
• Infectious disease research

Background:

• Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, poses a significant global health threat.
• Mutant variants, including Omicron, increase COVID-19 mortality and infection rates, necessitating advanced preventive strategies.
• Targeting viral entry is a key strategy for developing therapeutics and vaccines.

Purpose of the Study:

• To provide a comprehensive review of the structural aspects of SARS-CoV-2 viral entry.
• To analyze structural changes in Spike proteins during the distinct stages of viral entry.
• To examine the impact of Spike protein mutations on viral entry mechanisms and therapeutic development.

Main Methods:

• Analysis of structural changes in SARS-CoV-2 Spike proteins during prebinding, receptor binding, proteolytic cleavage, and membrane fusion.
• Review of existing literature on viral entry mechanisms and structural biology.
• Examination of the effects of mutations, including those in the Omicron variant, on Spike protein structure and function.

Main Results:

• Detailed insights into the atomic-scale structural dynamics of SARS-CoV-2 Spike protein during host cell entry.
• Understanding how mutations affect Spike protein structure and influence viral infectivity and immune evasion.
• Identification of critical structural points for intervention against viral entry.

Conclusions:

• Structural information on SARS-CoV-2 viral entry is vital for designing effective therapeutics and vaccines.
• Understanding Spike protein dynamics and mutation impacts guides structure-based drug and vaccine development.
• This review highlights the importance of structural analysis in combating SARS-CoV-2 and future viral threats.